ANI Pharmaceuticals Inc.

NASDAQ: ANIP · Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT

ANI Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-8.41M -19.24M -16.72M -5.29M 27.02M 35.55M 18.78M 13.38M -5.16M -26.33M -47.9M -67.79M -63.64M -62.82M -42.6M -22.1M -17.22M -15.45M
Depreciation & Amortization
84.52M 75.94M 67.73M 60.33M 59.78M 59.78M 59.79M 60.17M 60.31M 59.8M 59.65M 57.77M 53.76M 50.91M 47.25M 44.47M 44.48M 44.35M
Stock-Based Compensation
33.02M 31.28M 29.34M 27.9M 25.86M 23.25M 20.65M 18.77M 17.19M 15.7M 14.6M 13.83M 12.77M 11.86M 10.49M 9.91M 9.49M 12.38M
Other Working Capital
71.74M 34.1M 30.71M 15.34M 14.2M 8.32M 19.79M 10.57M -4.57M 12.2M 4.2M -8.95M -6.28M -13.5M -7.93M 5.27M 4.61M -1.96M
Other Non-Cash Items
18.93M 20.8M 16.76M 1.29M -8.31M -9.77M 6.62M 6.22M 11.57M 9.21M 8.99M 9.38M 5.33M 6.18M 5.02M 2.65M 2.76M 2.71M
Deferred Income Tax
-30.04M -28.4M -21.91M -12.73M -10.4M -9.41M -11.74M -5.02M -4.01M -7.02M -15.25M -21.72M -21.46M -23.94M -16.75M -12.84M -5.78M 5.76M
Change in Working Capital
41.11M 369K -11.19M 21.4M 18.63M 16.41M 24.86M -23.7M -38.63M -42.2M -51.3M -30.45M -34.78M -18.48M -84K -12.29M -20.14M -15.53M
Operating Cash Flow
139.14M 80.74M 64.02M 92.9M 112.59M 115.8M 118.96M 69.82M 41.27M 9.16M -31.2M -38.99M -48.01M -36.29M 3.32M 9.8M 13.59M 34.23M
Capital Expenditures
-31.78M -32.22M -16.95M -19.25M -18.36M -20.74M -18.51M -16.87M -22.14M -16.63M -16.45M -13.68M -4.45M -25.08M -23.64M -25.39M -30.61M -11.51M
Cash Acquisitions
-414.79M -414.79M -401.28M -393.08M 13.51M 13.51M n/a n/a -33K 684K 684K -83.81M -83.78M -84.49M -84.49M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-18.42M -18.42M -1.04M -959K n/a -4.33M -4.33M -4.33M -4.3M 775K 550K 3.2M 3.16M -18.61M -18.42M -21.08M -25.11M -6.22M
Investing Cash Flow
-435.96M -433.5M -404.72M -398.82M -4.85M -7.22M -18.51M -16.87M -22.14M -15.91M -15.74M -94.81M -85.58M -106.92M -105.48M -25.39M -30.61M -11.51M
Debt Repayment
342.66M 343.94M 345.22M 346.5M -3M -3M -3M -3M -3M -3M -3M 80.81M 78.73M 76.65M 75.02M -10.41M -9.96M -17.01M
Common Stock Repurchased
-11.55M -12.3M -10.96M -10.87M -10.86M -10.1M -4.99M -4.88M -4.44M -4.39M -1.96M -1.84M -1.68M -1.66M -890K 634K 707K 140K
Dividend Paid
-1.63M -1.63M -1.63M -1.63M -1.63M -1.63M -1.63M -1.63M -1.63M -1.63M -1.63M -1.41M -1M -595K -190K n/a n/a n/a
Other Financial Acitivies
-46.8M -46.8M -59.25M -78.27M -20.44M -23.24M -13.17M -1.87M -1.39M 1.61M 1.46M 97.27M 96.66M 120.66M 120.65M 24.24M 24.36M 337K
Financial Cash Flow
274.47M 274.76M 264.94M 257.93M -29.34M 52.26M 67.44M 78.85M 74.18M -7.4M -5.13M 174.83M 172.72M 195.05M 194.59M 12.94M 13.59M -18.05M
Net Cash Flow
-22.28M -78.76M -76.23M -48.06M 78.4M 160.84M 167.89M 131.79M 93.32M -14.15M -52.07M 41.03M 39.12M 51.84M 92.43M -2.65M -3.44M 4.66M
Free Cash Flow
111.37M 48.52M 47.06M 73.64M 94.23M 95.06M 100.45M 52.95M 19.14M -7.47M -47.66M -52.67M -52.46M -61.37M -20.32M -15.59M -17.03M 22.71M